UPDATED May 17, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FIB | лв4.36 | 12.4% | 111.7% | лв650.0m | n/a | PB0.4x | n/a | n/a | Banks | ||
CCB | лв1.61 | -3.0% | 13.4% | лв204.7m | n/a | PB0.3x | n/a | n/a | Banks | ||
SO | лв19.70 | -6.2% | n/a | лв203.1m | n/a | PE16.6x | n/a | 0% | Food, Beverage & Tobacco | ||
THQM | лв17.30 | -0.6% | 9.5% | лв1.5b | n/a | PE525.2x | n/a | 0% | Pharmaceuticals & Biotech | ||
MSH | лв11.40 | -3.4% | 20.0% | лв449.5m | n/a | PE12.6x | n/a | 3.5% | Capital Goods | ||
SPDY | лв162.00 | 1.3% | 47.3% | лв892.7m | n/a | PE20.9x | n/a | 3.2% | Transportation | ||
235H | лв48.60 | 0% | n/a | лв248.3m | n/a | PE288.7x | n/a | n/a | Real Estate Management and Development | ||
SFT | лв5.90 | 1.7% | 1.7% | лв202.2m | n/a | PE6.7x | n/a | 0% | Healthcare | ||
BACB | лв12.80 | 4.1% | n/a | лв316.0m | n/a | PB0.9x | n/a | 0.8% | Banks | ||
ATOM | лв13.00 | 0% | n/a | лв199.6m | n/a | PE12x | n/a | 0.2% | Commercial Services | ||
SFA | лв6.08 | 1.7% | 3.1% | лв1.0b | лв7.14 | PE10.6x | n/a | 14.8% | Pharmaceuticals & Biotech | ||
SLYG | лв73.00 | 5.5% | 194.4% | лв1.3b | лв61.68 | PE39.2x | E29.4% | 0.3% | Tech |